coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Surrey Heath PCN, Surrey Heath · Health Inequalities Profile

    PCN U67032 · NHS Frimley Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    101,996

    Registered population

    59.9% aged 18–64

    20.5%

    Aged 65+

    ICB 15.7% · England 17.9%

    14.2%

    Ethnic minority (non-White)

    8.5% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 3.0% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    15,545

    Hypertension register

    +2.66% in 3 yrs · England +5.60%

    662

    SMI register

    92.6% of Surrey Heath's

    1,363

    COPD register

    Reviews +39.83% in 3 yrs

    Forecast to 2030

    17,073

    Hypertension patients, 2030

    +1,528 on today

    70.0%

    QRISK ≥20% on statins, 2030

    +4.97pp over 3 yrs

    5.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    62.7%
    Asthma review rate trails England and ICB.

    Annual asthma reviews reached 62.7% (England 65.7%, ICB 68.4%), leaving about 2,200 of 6,012 register patients unreviewed, which may reflect recall gaps.

    58.6%
    High-risk lipid therapy lags alongside higher costs.

    Lipid therapy in QRISK ≥ 20% is 58.6% (England 63.6%, ICB 64.7%), while lipid-modifying prescribing costs £98,151 more than at England's unit cost.

    +39.8%
    COPD and heart failure reviews rose sharply.

    From 2023 to 2025, COPD reviews rose +39.8% to 80.2% (England 76.4%) and heart failure reviews rose +15.5% to 83.1% (England 78.5%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    An older population with 20.5% aged 65+ shapes primary care and frailty demand

    Surrey Heath PCN comprises 101,996 registered patients. Older adults aged 65+ account for 20.5% (20,933 patients), exceeding Surrey Heath (19.3%), NHS Frimley ICB (15.7%) and England (17.9%). Unverified projections indicate 3.3% list growth to 2030 (Surrey Heath 2.8%, ICB 2.5%, England 2.3%). Based on area Census residents rather than GP registers, White groups comprise 85.8% (Surrey Heath 85.0%, ICB 74.1%, England 81.1%), Asian groups 8.5% (Surrey Heath 8.9%, ICB 17.3%, England 9.6%), and Gypsy or Irish Traveller residents 0.4% (Surrey Heath 0.2%, ICB 0.2%, England 0.1%).

    Age profile

    0–1719.5%
    18–6459.9%
    65+20.5%

    65+: ICB 15.7%, England 17.9%

    Ethnicity

    White85.8%
    Asian8.5%
    Mixed2.6%
    Other1.7%
    Black1.5%

    Older people · falls rows are Surrey Heath local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Surrey Heath LA)1,6382,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.5%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.0%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Surrey Heath LA)7269819552024/25
    Falls deaths, all ages, per 100,000 (Surrey Heath LA)12.114.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 0.0% across all practices, with an average IMD decile of 8.4

    Core20 deprivation is 0.0%, matching Surrey Heath (0.0%), below NHS Frimley ICB (3.0%) and England (21.0%). Average IMD decile is 8.4 against Surrey Heath's 8.6, the ICB's 7.5 and England's 5.5 decile, with 0 Core20 residents across 72 LSOAs. All seven practices record 0.0% Core20 share. The PCN accounts for 92.6% of the borough severe mental illness register (662 patients) and 93.7% of the learning disability register (472 patients). Blood pressure checks for severe mental illness trail NHS Frimley ICB (79.9% versus 87.0%), highlighting an outreach focus.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Bartlett0.0% · 0 patients
    Park House0.0% · 0 patients
    Station Road0.0% · 0 patients
    Park Road0.0% · 0 patients
    Upper Gordon Road0.0% · 0 patients
    Camberley0.0% · 0 patients
    Lightwater0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    662

    SMI register

    0.64% recorded prevalence

    472

    Learning disability register

    0.46% recorded prevalence

    42

    Care homes, 1,978 beds

    In the PCN catchment

    7.5%

    Provide unpaid care

    Surrey Heath, Census 2021

    The PCN records 472 learning disability patients (0.5% prevalence) and 662 severe mental illness patients, representing 93.7% and 92.6% of borough registers respectively, alongside 42 catchment care homes with 1,978 beds. Unlinked borough data includes an autumn snapshot of 10 rough sleepers in 2025 and an estimated ceiling of 7,650 unpaid carers.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks reached 79.9% (Surrey Heath 80.5%, England 83.4%, NHS Frimley ICB 87.0%) and BMI checks reached 79.5% (Surrey Heath 79.1%, England 82.1%, ICB 87.2%). Trailing ICB completion could reflect recall gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    15,545

    Hypertension register

    +2.66%

    Register growth, 3 yrs

    Surrey Heath +3.31% · England +5.60%

    +6.16pp

    BP control, under 80

    ≤140/90 · +4.68pp aged 80+

    +1,528

    More patients by 2030

    Forecast 17,073 (15.81%)

    Hypertension case-finding and control

    Hypertension register prevalence is 15.0% (15,545 patients), compared with 14.8% in Surrey Heath, 14.4% in NHS Frimley ICB and 15.2% in England. Over 2023 to 2025, register growth was +2.7% (Surrey Heath +3.3%, ICB +4.1%, England +5.6%). Recorded blood pressure checks stand at 87.5% (Surrey Heath 87.4%, ICB 90.1%, England 90.0%). Blood pressure control under age 80 is 66.5% (Surrey Heath 66.3%, ICB 69.6%, England 67.8%), and treatment to target is 69.3% (Surrey Heath 69.4%, ICB 71.6%, England 70.3%). Proactive recall for unmanaged hypertensive patients could help narrow gaps to ICB and national control benchmarks.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy reached 58.6% (Surrey Heath 59.0%, England 63.6%, NHS Frimley ICB 64.7%), following +9.3% change over 2023 to 2025 (Surrey Heath +8.6%, ICB +5.0%, England +6.2%). Prioritising recall of eligible high-risk patients may address treatment shortfalls.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026153,361£2.50£2.23£1.86£383,402
    Cardiovascular (all), 2025215,706£4.18£4.03£3.33£901,651

    In 2026, the PCN prescribed 153,361 lipid-regulating drug items at £2.50 per item (Surrey Heath £2.49, NHS Frimley ICB £2.23, England £1.86). The PCN spent £98,151 more than at England's unit cost across 153,361 items. Prescribing choices across member practices drive higher spend than ICB and national benchmarks.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +8.79%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.18%

    Asthma prevalence, PCN 3-yr % change

    COPD reviews reached 80.2% after a +39.8% three-year increase over 2023 to 2025, exceeding Surrey Heath (79.9%), NHS Frimley ICB (79.4%) and England (76.4%). Conversely, asthma reviews reached 62.7% (Surrey Heath 62.5%, England 65.7%, ICB 68.4%), leaving about 2,200 of 6,012 registered patients without a recorded review. Asthma smoking status recording at ages 6-19 was 72.1% (Surrey Heath 72.6%, England 78.8%, ICB 81.3%). Proactive recall could close gaps in adult and paediatric asthma reviews.

    Cancer register and children's immunisation

    Cancer prevalence is 4.0% (4,126 patients; Surrey Heath 4.1%, NHS Frimley ICB 3.6%, England 3.8%). In Q1 2025/26 at age five, MMR dose 1 reached 95.7% (ICB 93.3%, England 91.7%). However, MMR dose 2 reached 88.8% (ICB 88.0%, England 82.8%), showing a 6.9 pp difference, and the 4-in-1 booster reached 88.4% (ICB 87.4%, England 80.9%), both below the 95.0% target. Recall drop-off after age one may explain slower pre-school booster completion.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.1%

    England 91.0%

    6-in-1 complete primary course at 24 months97.7%

    England 92.2%

    MMR dose 1 at 24 months94.2%

    England 88.3%

    MMR dose 2 at age 588.8%

    England 82.8%

    4-in-1 pre-school booster at age 588.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    57.3%

    Frimley ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~500

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Frimley ICBEnglandNo usable stageStaged cancers
    Breast82.3%85.4%21%537
    Prostate52.0%53.2%22%440
    Bowel50.2%47.0%17%406
    Lung33.3%33.8%16%324
    Skin cancer84.4%87.8%17%225

    In 2022, 57.3% of cancers with a known stage in NHS Frimley ICB were diagnosed at stage 1 or 2 (1,622 of 2,830 staged cases; England 55.3%), with a distance of -17.7 pp to the 75.0% national ambition by 2028, representing about 500 extra early-stage cases a year. Known-stage share was 67.8% (2,830 of 4,174 cases). Bowel cancer early diagnosis was 50.2% (204 of 406 staged cases). At PCN level, cervical screening coverage is 69.9% (England 66.8%), falling -1.9% over three years. Screening uptake and prompt referral in primary care are key to improving early staging across the system.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Jul 2026 (provisional) figures describe trust and ICB waiting times rather than PCN delivery. Frimley Health NHS Foundation Trust achieved 81.8% on the 62-day referral to treatment standard (85.0% standard; -3.2 pp distance), ahead of England (71.2%) and NHS Surrey and Sussex Integrated Care Board (71.5%), but below Royal Surrey NHS Foundation Trust (84.5%). On the 28-day faster diagnosis standard (75.0% standard), Frimley Health achieved 87.9% (12.9 pp distance), exceeding Ashford and St Peter's Hospitals NHS Foundation Trust (85.5%), Royal Surrey NHS Foundation Trust (82.6%) and England (79.3%).

    Pathways within standard (%)Frimley HealthRoyal SurreyAshford and St Peter'sSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)87.9582.6285.5379.2979.32
    31-day treatment (96%)92.8996.4394.2190.4592.50
    62-day referral to treatment (85%)81.8484.4876.3871.5171.16
    Diagnostic waits over 6 weeks (%)Frimley HealthRoyal SurreyAshford and St Peter'sEngland
    MRI12.850.000.0921.40
    CT0.630.159.279.92
    Echocardiography3.351.550.9728.48
    Colonoscopy22.840.0049.6130.83
    Gastroscopy7.430.0056.7429.02
    All 15 DM01 tests7.498.8223.1223.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In Jun 2026 (provisional), community services recorded 109,530 contacts for Surrey Heath borough residents, of which 76,215 involved adults aged 65 and over (69.6%). These figures describe borough resident activity across the wider health economy rather than PCN-level delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 48.9 pp and vaccination achievement varies by 58.2 pp across practices

    Overall 2025/26 QOF achievement ranges from 92.4% at Upper Gordon Road Surgery to 98.1% at Station Road Surgery (England 92.5%). Vaccination and immunisation achievement reveals wider variation, spanning 58.2 pp from 39.2% at Upper Gordon Road Surgery to 97.4% at Station Road Surgery (England 55.2%). High overall scores may mask substantial domain-specific variation.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Lightwater Surgery1080.086.6%75.0%95.2%
    Station Road1250.081.0%73.3%90.5%
    Park House Surgery1050.049.2%77.1%83.0%
    Camberley1020.060.9%51.8%81.0%
    Park Road1060.056.0%67.6%78.7%
    Bartlett970.037.6%81.4%77.0%
    Upper Gordon Road960.040.9%68.6%65.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSurrey HeathAssetPCNSurrey Heath
    Care homes (catchment)42 (1,978 beds)n/aSchools (catchment)99n/a
    Children's centres86Places of worship5237
    Libraries43Homelessness support (VCS)0no data
    Day centres (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)95Primary academies2622
    Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma review completion is 62.7% (Surrey Heath 62.5%, England 65.7%, NHS Frimley ICB 68.4%), leaving 2,244 (about 2,200) of 6,012 registered patients without a recorded review. For discussion: practices could run a shared recall template with flexible slots, reviewing inhaler prescribing alongside annual asthma checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Stroke and dementia register audit

    Stroke prevalence is 1.7% (1,785 patients; Surrey Heath 1.7%, England 1.9%; range -18 to +141 patients) with -2.5% 3-year change (England +2.3%); dementia changed by -5.2% (England +6.0%). For discussion: practices could search clinical records and care home lists for patients with stroke or dementia history lacking a register code. Low cost, quick to run.

    Evidence base: the stroke/TIA register is the cohort for AF anticoagulation and blood-pressure control (pre-stroke prevention) as well as hyperacute care; practices well below expected prevalence are the case-finding list, and the pre-stroke prevention gap concentrates in deprived practices.

    Policy anchor: Core20PLUS5 (CVD); NHS CVD ambitions to 2029.

    Option 3

    High-risk lipid therapy and formulary review

    Lipid-lowering therapy in QRISK ≥ 20% is 58.6% (England 63.6%, ICB 64.7%) and statin therapy in diabetes is 71.3% (ICB 75.1%), while lipid-modifying prescribing costs £98,151 more than at England's unit cost across 153,361 items. Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Traveller community outreach review (p2)Gypsy or Irish TravellerNeighbourhood health framework · Core20PLUS5 approachPCN
    Severe mental illness check outreach (p3)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    SMI physical health recall clinics (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertensive blood pressure recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Stroke and dementia register audit (p12)Stroke register · Stroke: QOF prevalence · Dementia: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT · SSNAP · 66.7% diagnosis ambition · 95% care plan 2027PCN
    Option 3 · High-risk lipid therapy and formulary review (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs) · Cost per item for Lipid-regulating drugs 2026NHS Long Term Plan (diabetes) and National Diabetes AuditPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15